FDA Public Education On ED Drug Vision Risk Is Lacking, Sen. Grassley Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate Finance Committee chair seeks FDA strategy for disseminating drug safety information to patients not requiring physician follow-up.